Background
What it is, how it developed and why it is discussed
TB-500 is a synthetic peptide associated with research on thymosin beta-4 biology, including cell migration and tissue-repair pathways. Therapeutic claims substantially exceed the available controlled human evidence.
Evidence
Evidence, limitations and clinical context
SAHPRA specifically lists TB-500 among illegally marketed peptides. Direct online sale remains disabled unless a lawful registered or authorised supply pathway is confirmed.
Clinical access
Not available for routine online purchase
This treatment is not enabled for routine online sale. A doctor can discuss the evidence, suitability and lawful alternatives. Where an unregistered medicine is considered clinically necessary, any access must follow the applicable SAHPRA authorisation process before supply.
Clinical assessment Clinician authorisation
